Utilizing the antibodies from the plasma of survivors of the coronavirus to help those who are critically ill from the coronavirus has been deemed successful:

In trial, 10 severely-ill patients made recoveries after receiving antibodies from people who had successfully fought the Covid-19 virus

Premium.